WO2011109031A8 - Methods for cloning and manipulating genomes - Google Patents

Methods for cloning and manipulating genomes Download PDF

Info

Publication number
WO2011109031A8
WO2011109031A8 PCT/US2010/035490 US2010035490W WO2011109031A8 WO 2011109031 A8 WO2011109031 A8 WO 2011109031A8 US 2010035490 W US2010035490 W US 2010035490W WO 2011109031 A8 WO2011109031 A8 WO 2011109031A8
Authority
WO
WIPO (PCT)
Prior art keywords
methods
cloning
genomes
donor
host cell
Prior art date
Application number
PCT/US2010/035490
Other languages
French (fr)
Other versions
WO2011109031A1 (en
Inventor
Gwynedd A. Benders
John I. Glass
Clyde A. Hutchison
Carole Lartigue
Sanjay Vashee
Mikkel A. Algire
Hamilton O. Smith
Charles E. Merryman
Vladimir N. Noskov
Ray-Yuan Chuang
Daniel G. Gibson
J. Craig Venter
Original Assignee
Synthetic Genomics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/718,911 external-priority patent/US9273310B2/en
Application filed by Synthetic Genomics, Inc. filed Critical Synthetic Genomics, Inc.
Priority to JP2012556048A priority Critical patent/JP2013520989A/en
Priority to CN2010800666205A priority patent/CN102939380A/en
Priority to EP10726723A priority patent/EP2542676A1/en
Publication of WO2011109031A1 publication Critical patent/WO2011109031A1/en
Publication of WO2011109031A8 publication Critical patent/WO2011109031A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1031—Mutagenizing nucleic acids mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Compositions and methods are disclosed herein for cloning a synthetic or a semi-synthetic donor genome in a heterologous host cell. In one embodiment, the donor genome can be further modified within a host cell. Modified or unmodified genomes can be further isolated from the host cell and transferred to a recipient cell. Methods disclosed herein can be used to alter donor genomes from intractable donor cells in more tractable host cells.
PCT/US2010/035490 2010-03-05 2010-05-19 Methods for cloning and manipulating genomes WO2011109031A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2012556048A JP2013520989A (en) 2010-03-05 2010-05-19 Methods for genome cloning and manipulation
CN2010800666205A CN102939380A (en) 2010-03-05 2010-05-19 Methods for cloning and manipulating genomes
EP10726723A EP2542676A1 (en) 2010-03-05 2010-05-19 Methods for cloning and manipulating genomes

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12/718,911 US9273310B2 (en) 2007-10-08 2010-03-05 Methods for cloning and manipulating genomes
US12/718,911 2010-03-05
US32226910P 2010-04-08 2010-04-08
US61/322,269 2010-04-08

Publications (2)

Publication Number Publication Date
WO2011109031A1 WO2011109031A1 (en) 2011-09-09
WO2011109031A8 true WO2011109031A8 (en) 2012-09-20

Family

ID=42697547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/035490 WO2011109031A1 (en) 2010-03-05 2010-05-19 Methods for cloning and manipulating genomes

Country Status (4)

Country Link
EP (1) EP2542676A1 (en)
JP (1) JP2013520989A (en)
CN (1) CN102939380A (en)
WO (1) WO2011109031A1 (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2734621B1 (en) 2011-07-22 2019-09-04 President and Fellows of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20130109596A1 (en) 2011-09-26 2013-05-02 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
US9206435B2 (en) 2012-08-31 2015-12-08 Synthetic Genomics, Inc. Crowding agent-induced nucleic acid transfer into a recipient host cell
US10563240B2 (en) 2013-03-14 2020-02-18 Life Technologies Corporation High efficiency, small volume nucleic acid synthesis
CN116042726A (en) * 2013-07-09 2023-05-02 哈佛大学校长及研究员协会 Multiplex RNA guided genome engineering
PL3030682T3 (en) 2013-08-05 2020-11-16 Twist Bioscience Corporation De novo synthesized gene libraries
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9834791B2 (en) 2013-11-07 2017-12-05 Editas Medicine, Inc. CRISPR-related methods and compositions with governing gRNAS
US9840699B2 (en) 2013-12-12 2017-12-12 President And Fellows Of Harvard College Methods for nucleic acid editing
CA2956224A1 (en) 2014-07-30 2016-02-11 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
CN107532129B (en) 2014-12-09 2022-09-13 生命技术公司 Efficient small volume nucleic acid synthesis
WO2016126882A1 (en) 2015-02-04 2016-08-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
WO2016172377A1 (en) 2015-04-21 2016-10-27 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
KR20180050411A (en) 2015-09-18 2018-05-14 트위스트 바이오사이언스 코포레이션 Oligonucleotide mutant library and its synthesis
US11512347B2 (en) 2015-09-22 2022-11-29 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
US10167457B2 (en) 2015-10-23 2019-01-01 President And Fellows Of Harvard College Nucleobase editors and uses thereof
CN115920796A (en) 2015-12-01 2023-04-07 特韦斯特生物科学公司 Functionalized surfaces and preparation thereof
SG11201900907YA (en) 2016-08-03 2019-02-27 Harvard College Adenosine nucleobase editors and uses thereof
CN109804066A (en) 2016-08-09 2019-05-24 哈佛大学的校长及成员们 Programmable CAS9- recombination enzyme fusion proteins and application thereof
AU2017315294B2 (en) 2016-08-22 2023-12-21 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
JP6871364B2 (en) 2016-09-21 2021-05-12 ツイスト バイオサイエンス コーポレーション Nucleic acid-based data storage
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
US10907274B2 (en) 2016-12-16 2021-02-02 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
JP2020508661A (en) 2017-02-22 2020-03-26 ツイスト バイオサイエンス コーポレーション Nucleic acid based data storage
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165629A1 (en) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Cytosine to guanine base editor
WO2018170169A1 (en) 2017-03-15 2018-09-20 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
CA3054337A1 (en) * 2017-03-17 2018-09-20 Syngenta Participations Ag Methods and compositions for preserving tissues and nucleic acids
US11268082B2 (en) 2017-03-23 2022-03-08 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable DNA binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
WO2018231864A1 (en) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
KR102628876B1 (en) 2017-06-12 2024-01-23 트위스트 바이오사이언스 코포레이션 Methods for seamless nucleic acid assembly
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
KR20200047706A (en) 2017-09-11 2020-05-07 트위스트 바이오사이언스 코포레이션 GPCR binding protein and method for synthesis thereof
CN111757937A (en) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 Use of adenosine base editor
CN107784199A (en) * 2017-10-18 2018-03-09 中国科学院昆明植物研究所 A kind of organelle gene group screening technique based on STb gene sequencing result
CN111565834B (en) 2017-10-20 2022-08-26 特韦斯特生物科学公司 Heated nanopores for polynucleotide synthesis
CA3088911A1 (en) 2018-01-04 2019-07-11 Twist Bioscience Corporation Dna-based storage device and method for synthesizing polynucleotides using the device
AU2019270243A1 (en) 2018-05-18 2021-01-07 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
CA3131691A1 (en) 2019-02-26 2020-09-03 Twist Bioscience Corporation Variant nucleic acid libraries for antibody optimization
AU2020229349A1 (en) 2019-02-26 2021-10-14 Twist Bioscience Corporation Variant nucleic acid libraries for GLP1 receptor
BR112021018607A2 (en) 2019-03-19 2021-11-23 Massachusetts Inst Technology Methods and compositions for editing nucleotide sequences
AU2020298294A1 (en) 2019-06-21 2022-02-17 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
WO2021061829A1 (en) 2019-09-23 2021-04-01 Twist Bioscience Corporation Variant nucleic acid libraries for crth2
EP4142784A2 (en) 2020-04-27 2023-03-08 Twist Bioscience Corporation Variant nucleic acid libraries for coronavirus
JP2023525304A (en) 2020-05-08 2023-06-15 ザ ブロード インスティテュート，インコーポレーテッド Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
US11970697B2 (en) 2020-10-19 2024-04-30 Twist Bioscience Corporation Methods of synthesizing oligonucleotides using tethered nucleotides
CN116042688B (en) * 2023-03-06 2023-06-20 中山大学 Citrus canker high-saturation transposon mutant library and construction method thereof
CN116769797B (en) * 2023-08-14 2023-10-24 浙江大学海南研究院 Application of methyl jasmonate and PpyMYC2 gene in germination

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5721118A (en) 1995-10-31 1998-02-24 The Regents Of The University Of California, San Diego Mammalian artificial chromosomes and methods of using same
US5866404A (en) 1995-12-06 1999-02-02 Yale University Yeast-bacteria shuttle vector
US6025155A (en) 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
AU5217599A (en) 1998-07-27 2000-02-21 Genotypes, Inc. Automatic eukaryotic artificial chromosome vector
AU5597200A (en) 1999-06-07 2000-12-28 Cell Genesys, Inc. Hybrid yeast-bacteria cloning system and uses thereof
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
DK1929012T3 (en) 2005-08-11 2011-01-31 Synthetic Genomics Inc Method of in vitro recombination
WO2007021944A2 (en) 2005-08-11 2007-02-22 The J. Craig Venter Institute In vitro recombination method
AU2006347573B2 (en) * 2005-12-06 2013-01-17 Synthetic Genomics, Inc. Synthetic genomes
JP2009521229A (en) * 2005-12-23 2009-06-04 ジェイ．クレイグ ベンター インスティチュート Installing genomes or partial genomes into cells or cell-like systems
US9481880B2 (en) * 2007-05-01 2016-11-01 Synthetic Genomics, Inc. Methods of genome installation in a recipient host cell
MX2010003644A (en) 2007-10-08 2010-06-23 Synthetic Genomics Inc Assembly of large nucleic acids.
US9758810B2 (en) * 2008-04-28 2017-09-12 Synthetic Genomics, Inc. Identification of centromere sequences and uses therefor
SG10201400436PA (en) * 2009-03-06 2014-06-27 Synthetic Genomics Inc Methods For Cloning And Manipulating Genomes

Also Published As

Publication number Publication date
EP2542676A1 (en) 2013-01-09
CN102939380A (en) 2013-02-20
JP2013520989A (en) 2013-06-10
WO2011109031A1 (en) 2011-09-09

Similar Documents

Publication Publication Date Title
WO2011109031A8 (en) Methods for cloning and manipulating genomes
WO2010102257A3 (en) Methods for cloning and manipulating genomes
PH12017501078A1 (en) Strains of agrobacterium modified to increase plant transformation frequency
WO2010088633A3 (en) Novel cell lines and methods
EP3413908A4 (en) Methods and compositions for modifying a mutant dystrophin gene in a cell's genome
WO2016201047A8 (en) Crispr/cas-related methods and compositions for improving transplantation
WO2011053144A3 (en) Methods and compositions for dysferlin exon-skipping
MX336846B (en) Targeted genomic alteration.
EP3194570A4 (en) Methods and compositions for nuclease-mediated genome engineering and correction in hematopoietic stem cells
IN2014DN09261A (en)
WO2009006297A3 (en) Methods for altering the genome of a monocot plant cell
WO2010120785A3 (en) Methods and compositions for stem cell cultures
EP3057432A4 (en) Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells
WO2011085247A3 (en) Vectors and methods for transducing b cells
WO2011156654A3 (en) Pathways characterization of cells
WO2011160021A3 (en) Fullerene derivatives and photovoltaic cell containing them
WO2009102569A3 (en) Cell lines and methods for making and using them
GB2489187B (en) Compositions, methods and related uses for cleaving modified DNA
WO2010042749A3 (en) Chimeric therapeutics, compositions, and methods for using same
EP3128591A4 (en) Collector for fuel cells, and fuel cell
WO2010042751A3 (en) Chimeric therapeutics, compositions, and methods for using same
GB2462569A (en) Primate stem cells produced by somatic cell nuclear transfer
AU2008254291A8 (en) Methods of genome installation in a recipient host cell
HK1200329A1 (en) Truncated hiv envelope proteins (env), methods and compositions related thereto hiv (env)
WO2012136909A3 (en) Thixotropic α-lactalbumin hydrogels, method for preparing same and uses thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080066620.5

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10726723

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2012556048

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2010726723

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010726723

Country of ref document: EP